Patent intelligence · AT
AT E203027
PENEMDERIVATE, DEREN HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
PENEMDERIVATE, DEREN HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
Patent details — AT E203027
- Jurisdiction
- AT
- Status
- expired
- Grant date
- Jul 15, 2001
- Expiration
- Jul 10, 2021
- Applicant
- MENARINI FARMA IND [IT]
- CPC classes
- A61K 31/ 43 A I, A61K 31/ 48 A I, A61K31/43, A61P 31/ 04 A I
Quick answer
AT E203027 (PENEMDERIVATE, DEREN HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN) is held by MENARINI FARMA IND [IT]. Status: expired. Granted Jul 15, 2001. Expires Jul 10, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MENARINI FARMA IND [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 43 A I, A61K 31/ 48 A I, A61K31/43, A61P 31/ 04 A I, A61P/3104
More from MENARINI FARMA IND [IT]
Related pharmaceutical patents in our USPTO index.
-
IT 201700031902
Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.
granted -
CA 2682039
PREPARATIONS COSMETIQUES VISANT A REDUIRE LA CELLULITE DISGRACIEUSE
granted -
EP 1526849
TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON
expired -
US 6150325
Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
expired
Frequently asked questions
What is US patent E203027?
AT E203027 (PENEMDERIVATE, DEREN HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN) is held by MENARINI FARMA IND [IT]. Status: expired. Granted Jul 15, 2001. Expires Jul 10, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AT E203027?
MENARINI FARMA IND [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.
When does AT E203027 expire?
Our index shows an expiration date of Jul 10, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.